Brief: Aurobindo Pharma Says US FDA Classifies Unit's Raleigh Plant As Voluntary Action Indicated
17/08/2026 03:44
BRIEF-Aurobindo Pharma Says US FDA Classifies Unit's Raleigh Plant As Voluntary Action Indicated Aug 17 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA - CLASSIFICATION OF US FDA INSPECTION AT UNIT'S RALEIGH PLANT AS VOLUNTARY ACTION INDICATED
AUROBINDO PHARMA - AT END OF INSPECTION, FORM 483 WAS ISSUED WITH TOTAL OF 11 OBSERVATIONS
Further company coverage: ARBN.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11